Raffaele Calogero

From Top Italian Scientists Wiki

Raffaele Calogero is currently Associate Professor of Molecular Biology, at the Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy.[1]

Raffaele Calogero
March, 03, 1960, Torino, Italy
University of Naples “Federico II” (Italy)
Bioinformatics; Molecular Biology.
University of Naples “Federico II”, Italy (1992-1998)
University of Turin, Italy (1998-Present)
Top Italian Scientist in Biomedical Sciences [2]

Education and career

Raffaele Calogero graduated in Biological Sciences from the University of Naples “Federico II” in 1984. He spent two years (1985-1988) at Max Plank Institute fuer Mulekulare Genetic, Berlin (Germany) as research fellow. Since 1989 to 1992, he got a position a research scientist at SORIN Biomedica S.p.A. (Italy). He was appointed as associated professor at University of Naples “Federico II” in 1992 and he moved to University of Turin in 1998. He is the founder of the Reproducible Bioinformatics Project[3], which is a community of developers focusing on the production of reproducible bioinformatics workflows. Since 2018, he is the representative for University of Turin at the General Assembly of Elixir Italian Node[4]. Since 2021, he is the president of the Bioinformatics Italian Society (BITS)[5]. Since 2022, he is part of the steering committee of the FISV[6].

Research Interests

Raffaele Calogero research experience focuses on the development, optimization of bioinformatics analysis workflows and on mining transcription-based experiments, mainly in the oncology framework. An important aspect of his past and present work is the constant interest on new technologies (e.g. today single-cell omics and spatial transcriptomics) and their integration in bioinformatics analysis workflows.


The scientific results achieved by Raffaele Calogero are reported in over 180 peer-reviewed papers [6]. Raffaele Calogero has an H-index of 44 (according to SCOPUS[7]). Raffaele Calogero is also editor, together with Vladimir Benes, of the Book: “Single cell transcriptomics”, published by Springer in 2023[8].

Selected Publications

  • Christodoulou C, Spencer JA, Yeh SA, Turcotte R, Kokkaliaris KD, Panero R, Ramos A, Guo G, Seyedhassantehrani N, Esipova TV, Vinogradov SA, Rudzinskas S, Zhang Y, Perkins AS, Orkin SH, Calogero RA, Schroeder T, Lin CP, Camargo FD. Live-animal imaging of native haematopoietic stem and progenitor cells. Nature. 2020 Feb;578(7794):278-283. doi: 10.1038/s41586-020-1971-z. Epub 2020 Feb 5. PMID: 32025033; PMCID: PMC7021587.
  • Bucci E, Andreev K, Björkman A, Calogero RA, Carafoli E, Carninci P, Castagnoli P, Cossarizza A, Mussini C, Guerin P, Lipworth B, Sbardella G, Stocki T, Tuosto L, van Tulleken C, Viola A. Safety and efficacy of the Russian COVID-19 vaccine: more information needed. Lancet. 2020 Oct 3;396(10256):e53. doi: 10.1016/S0140-6736(20)31960-7. Epub 2020 Sep 21. PMID: 32971041; PMCID: PMC7503114.
  • Yuan WC, Pepe-Mooney B, Galli GG, Dill MT, Huang HT, Hao M, Wang Y, Liang H, Calogero RA, Camargo FD. NUAK2 is a critical YAP target in liver cancer. Nat Commun. 2018 Nov 16;9(1):4834. doi: 10.1038/s41467-018-07394-5. PMID: 30446657; PMCID: PMC6240092.
  • Rodriguez-Fraticelli AE, Wolock SL, Weinreb CS, Panero R, Patel SH, Jankovic M, Sun J, Calogero RA, Klein AM, Camargo FD. Clonal analysis of lineage fate in native haematopoiesis. Nature. 2018 Jan 11;553(7687):212-216. doi: 10.1038/nature25168. Epub 2018 Jan 3. PMID: 29323290; PMCID: PMC5884107.